In a recent cohort study from Ontario, Canada, among 489 women with a BRCA1 or BRCA2 sequence variation, the 20-year mortality from breast cancer after the first screening MRI examination was 2.0%. The difference between these 2 rates is small and may be due to chance. The gene discussed is BRCA2; the disease is breast carcinoma.